Repligen Corporation
RGEN
$157.39
-$4.27-2.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 188.81M | 182.37M | 169.17M | 167.55M | 154.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 188.81M | 182.37M | 169.17M | 167.55M | 154.87M |
| Cost of Revenue | 88.29M | 89.37M | 77.80M | 87.23M | 75.90M |
| Gross Profit | 100.52M | 93.00M | 91.37M | 80.31M | 78.97M |
| SG&A Expenses | 73.66M | 69.41M | 69.81M | 37.92M | 73.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 176.13M | 172.75M | 159.72M | 136.83M | 159.55M |
| Operating Income | 12.68M | 9.62M | 9.45M | 30.71M | -4.68M |
| Income Before Tax | 17.11M | 18.22M | 7.94M | -38.61M | -1.15M |
| Income Tax Expenses | 2.20M | 3.35M | 2.11M | -4.74M | -495.00K |
| Earnings from Continuing Operations | 14.91M | 14.87M | 5.83M | -33.87M | -654.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.91M | 14.87M | 5.83M | -33.87M | -654.00K |
| EBIT | 12.68M | 9.62M | 9.45M | 30.71M | -4.68M |
| EBITDA | 32.69M | 29.70M | 28.16M | 49.08M | 12.72M |
| EPS Basic | 0.27 | 0.26 | 0.10 | -0.60 | -0.01 |
| Normalized Basic EPS | 0.14 | 0.15 | 0.12 | 0.32 | 0.02 |
| EPS Diluted | 0.26 | 0.26 | 0.10 | -0.61 | -0.01 |
| Normalized Diluted EPS | 0.14 | 0.15 | 0.12 | 0.32 | 0.02 |
| Average Basic Shares Outstanding | 56.27M | 56.23M | 56.12M | 56.06M | 56.01M |
| Average Diluted Shares Outstanding | 56.53M | 56.51M | 56.56M | 56.06M | 56.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |